Novartis Investigative Site

Neuss, North Rhine-Westphalia 41464

0 studies enrolling now · 2 studies all time

What they study most

Cancer, Ovarian Cancer, Renal Cell Carcinoma (RCC)

Studies at this site

• Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) — Completed